For the quarter ended September 2025, Tempus AI (TEM) reported revenue of $334.21 million, up 84.7% over the same period last year. EPS came in at -$0.11, compared to -$0.25 in the year-ago quarter.
The reported revenue represents a surprise of +2.38% over the Zacks Consensus Estimate of $326.43 million. With the consensus EPS estimate being -$0.16, the EPS surprise was +31.25%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Tempus performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net Revenue- Data and services: $81.33 million versus $81.6 million estimated by five analysts on average.
- Net Revenue- Genomics: $252.88 million versus the five-analyst average estimate of $244.82 million.
- Non-GAAP Gross Profit- Genomics: $155.9 million versus $141.1 million estimated by three analysts on average.
- Non-GAAP Gross Profit- Data and Services: $56.66 million versus $60.07 million estimated by three analysts on average.
View all Key Company Metrics for Tempus here>>>
Shares of Tempus have returned -4.7% over the past month versus the Zacks S&P 500 composite's +2.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Tempus AI, Inc. (TEM): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
